Suppr超能文献

法国、德国和美国与纤维肌痛相关的卫生资源使用及成本。

Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States.

作者信息

Knight Tyler, Schaefer Caroline, Chandran Arthi, Zlateva Gergana, Winkelmann Andreas, Perrot Serge

机构信息

Health Economics and Outcomes Research, Covance Market Access Services, Gaithersburg, MD, USA.

出版信息

Clinicoecon Outcomes Res. 2013 Apr 23;5:171-80. doi: 10.2147/CEOR.S41111. Print 2013.

Abstract

BACKGROUND

Fibromyalgia (FM) is a chronic disorder characterized by widespread, persistent pain. Prospective and retrospective studies have demonstrated substantial health-care costs associated with FM in a number of countries. This study evaluated and compared health-resource use (HRU) and associated costs related to FM in routine clinical practice across the US, France, and Germany.

METHODS

Two separate, cross-sectional, observational studies of subjects with FM were conducted: one in the US and one in France and Germany. HRU related to prescription medication, physician office visits, diagnostic tests, and hospitalizations was abstracted from chart review; patient out-of-pocket costs and lost productivity were collected via subject self-report. Costs were assigned to HRU based on standard algorithms. Direct and indirect costs were evaluated and compared by simple linear regression.

RESULTS

A total of 442 subjects (203 US, 70 France, 169 Germany) with FM were analyzed. The mean (standard deviation) age in the US, France, and Germany was 47.9 (10.9), 51.2 (9.5), and 49.2 (9.8), respectively (P = 0.085). Most subjects were female (95% US, 83% France, 80% Germany) (P < 0.001). Adjusted annual direct costs per subject for FM were significantly higher in the US ($7087) than in France ($481, P < 0.001) or Germany ($2417, P < 0.001). Adjusted mean annual indirect costs per subject for FM were lower in the US ($6431) than in France ($8718) or Germany ($10,001), but represented a significant proportion of total costs in all countries.

CONCLUSION

The significant HRU and costs associated with FM in the US, France, and Germany documented in this study highlight the substantial global economic burden of FM. Indirect costs represented a significant proportion of the total costs, particularly in Europe. Comparisons between the three countries show differences in HRU, with significantly higher direct costs in the US compared with France and Germany.

摘要

背景

纤维肌痛(FM)是一种以广泛、持续性疼痛为特征的慢性疾病。前瞻性和回顾性研究表明,在许多国家,FM会带来大量医疗保健费用。本研究评估并比较了美国、法国和德国常规临床实践中与FM相关的卫生资源使用(HRU)及相关费用。

方法

对FM患者进行了两项独立的横断面观察性研究:一项在美国,另一项在法国和德国。通过病历审查提取与处方药、医生门诊、诊断测试和住院相关的HRU;通过受试者自我报告收集患者自付费用和生产力损失。根据标准算法将费用分配给HRU。通过简单线性回归评估和比较直接和间接费用。

结果

共分析了442例FM患者(203例美国患者、70例法国患者、169例德国患者)。美国、法国和德国患者的平均(标准差)年龄分别为47.9(10.9)岁、51.2(9.5)岁和49.2(9.8)岁(P = 0.085)。大多数患者为女性(美国95%、法国83%、德国80%)(P < 0.001)。美国FM患者调整后的人均年度直接费用(7087美元)显著高于法国(481美元,P < 0.001)或德国(2417美元,P < 0.001)。美国FM患者调整后的人均年度间接费用(6431美元)低于法国(8718美元)或德国(10001美元),但在所有国家中均占总成本的很大比例。

结论

本研究记录的美国、法国和德国与FM相关的大量HRU和费用凸显了FM巨大的全球经济负担。间接费用占总成本的很大比例,尤其是在欧洲。三国之间的比较显示了HRU的差异,美国的直接费用显著高于法国和德国。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b485/3637123/cb628cfcd72e/ceor-5-171Fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验